New FDA-Cleared Blood Test Moves Alzheimer’s Assessment into Primary Care
Roche’s Elecsys pTau181 assay gives clinical labs a key role in the initial evaluation of cognitive decline, helping to rule out amyloid pathology earlier in the diagnostic process.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
